Tesi Raymond Joseph 4
4 · Inmune Bio, Inc. · Filed Mar 23, 2022
Insider Transaction Report
Form 4
Inmune Bio, Inc.INMB
Tesi Raymond Joseph
DirectorPresident & CEO10% Owner
Transactions
- Award
Common Stock
2022-03-22$8.43/sh+23,724$199,993→ 1,514,398 total - Award
Option (right to buy)
2022-03-21+130,000→ 130,000 totalExercise: $7.92Exp: 2032-03-20→ Common Stock (130,000 underlying)
Footnotes (2)
- [F1]The purchase price of the common stock being reported is the closing price per share immediately preceding the entering into of the binding agreement to issue the securities . These shares were purchased by the Reporting Person directly from Issuer.
- [F2]Granted pursuant to the 2021 Stock Incentive Plan. One third (1/3) of the Option will vest at the one-year anniversary of the grant date and the remaining unvested Option will become vested and exercisable 1/24th every month thereafter until the Option is 100% vested which shall occur on the three-year anniversary of the grant date.